Quick search:
Content Ideas
| Result | Content Idea | Research |
|---|---|---|
| Result | Content Idea | Research |
| 1 | Exelixis to Host Investor Briefing to Discuss Data Presented at the American Society of Clinical Oncology's 2021 Genitourinary Cancers Symposium |
|
| 2 | ASCO Publishes 2021 Report on Progress Against Cancer |
|
| 3 | A Half-Century of Progress; Reflux and Cancer; More Positive News for AI |
|
| 4 | Richard Schilsky Bids Adieu to ASCO |
|
| 5 | Bon Secours helps to address racial & ethnic disparities in healthcare |
|
| 6 | ASCO's Early Breast Cancer Guidelines Updated to Include T-DM1 |
|
| 7 | Leading Expert in Women's Cancers Appointed Director of Gynecologic Oncology at Perlmutter Cancer Center |
|
| 8 | ASCO, Friends of Cancer Research recommend broadening eligibility criteria in cancer clinical trials |
|
| 9 | ASCO Partners With American Cancer Society to Recommend Prioritization of COVID-19 Vaccine for Cancer Patients |
|
| 10 | Langer Discusses Trials in Multiple Settings for Non–Small Cell Lung Cancer |
|
| 11 | ASCO GU 2021: Safety of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer From Extended F... |
|
| 12 | ASCO GU 2021: Use of Genomics to Guide Treatment Decisions in Post-Prostatectomy Patients |
|
| 13 | Oncology Peer Review On-The-Go: 1-on-1 With Richard L. Schilsky, MD, on Molecular Profiling in GI Cancers |
|
| 14 | Checkpoint Therapeutics Announces Formation of Scientific Advisory BoardMembers include preeminent clinical and scientific thought leaders in oncology |
|
| 15 | Decipher Test May Guide Post-Surgical Tx in Prostate Cancer |
|
| 16 | ASCO GU 2021: Best of Journals: Urothelial Cancer |
|
| 17 | Drinking Alcohol and Cancer: Should Your Cocktail Carry a Cancer Warning? |
|
| 18 | 10 stories for International HPV Awareness Day |
|
| 19 | ASCO GU 2021: Patient-Reported Outcomes Of Patients With Advanced Renal Cell Carcinoma Treated With First-L... |
|
| 20 | Radiation Therapy in SCLC -- ASCO Endorses ASTRO Guideline |
|
| 21 | ASCO GU 2021: Phase IIB Trial of Oral ModraDoc006/r as a Tolerable and Effective Option in Comparison with ... |
|
| 22 | European Congress of Radiology: Launch of The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine |
|
| 23 | ASCO GU 2021: Dose-intensification among Patients Receiving Salvage RT Following Radical Prostatectomy and ... |
|
| 24 | Simplify Health Care System to Improve Patient Care, Value |
|
| 25 | Florida Cancer Specialists to provide COVID-19 vaccinations to patients |
|
| 26 | Cancer Warning Labels on Alcohol: Calls for Congress to Act |
|
| 27 | Robert J. Motzer, MD, on a Phase 3 Trial Evaluating MK-6482 Plus Lenvatinib Versus Cabozantinib for Advanced ccRCC |
|
| 28 | ASCO GU 2021: Therapy-Relevant Gene Signatures In The High Risk Localized Renal Cell Carcinoma Setting: Tra... |
|
| 29 | Amgen to Acquire Five Prime for $1.9B, Adding Phase III Gastric Cancer Candidate |
|
| 30 | Strata Oncology, Pfizer Partner to Explore New Biomarker Indications for FDA-Approved Drugs |
|
| 31 | ASCO GU 2021: Efficacy and Safety of Avelumab plus Axitinib (A + Ax) Versus Sunitinib (S) in Elderly Patien... |
|
| 32 | ASCO Releases Recommendations for Postpandemic Cancer Care |
|
| 33 | Robert J. Motzer, MD, on Outcomes of the Phase 3 CheckMate 9ER Trial in Advanced RCC |
|
| 34 | Friday Frontline: Biden Holds Bipartisan Meeting on Cancer Research, Pediatric Patient 'Donates' Her Birthday to Help Other Children and More |
|
| 35 | Florida Cancer Specialists & Research Institute Breaks Ground for New Cancer Center in Orange City |
|
| 36 | American Society of Clinical Oncology Exclusively Cites myChoice® CDx in New Recommendations for Patients with Advanced Ovarian Cancer |
|
| 37 | Lenvima Plus Keytruda Associated With Better Results Than Sutent Alone in Patients With Advanced Type of Kidney Cancer |
|
| 38 | Michael Szarek, PhD, on the Next Steps for Tivozanib in Patients with Advanced RCC |
|
| 39 | Use of Molecular Assays and Circulating Tumor DNA in Early Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group (GICTEG) |
|
| 40 | Florida Cancer Specialists & Research Institute Opens New Location in Estero |
|
| 41 | Cancer patients stranded by dispute between oncologists, Anne Arundel Medical Center |
|
| 42 | BostonGene Announces Acceptance of Abstracts to the Annual Meeting of the American Society of Clinical Oncology 2020 |
|
| 43 | BriaCell Announces Presentation and Abstract Publication at 2020 American Society of Clinical Oncology (ASCO) Meeting |
|
| 44 | HEALTH COLUMN: Good health starts with you |
|
| 45 | ASCO Highlights: Takeda, Genentech, Johnson & Johnson and More |
|
| 46 | PDS Biotechnology Announces Publication at American Society of Clinical Oncology (ASCO) 2020 |
|
| 47 | Liquid biopsy for colorectal cancer could guide therapy for tumours: Study |
|
| 48 | BriaCell Presents Clinical Findings at 2020 American Society of Clinical Oncology (ASCO) Meeting |
|
| 49 | Incysus Therapeutics Announces Poster Presentation at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting |
|
| 50 | Oncolytics Biotech® Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights |
|
| 51 | BriaCell to Present Clinical Data at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting May 29 |
|
| 52 | Oncocyte Announces New Data to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting Demonstrating That the DetermaIO™ Gene Expression Test May Predict Response to Immunotherapy in Triple Negative Breast Cancer |
|
| 53 | COVID-19 Inspires Recommendations to Improve Cancer Care and Research |
|
| 54 | BeiGene Announces Clinical Data to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting |
|
| 55 | Disparities in Bladder Cancer Care Persist Despite Years of Evidence |
|
| 56 | AVEO Oncology Announces Presentation of Key Subgroup and Quality of Life Analyses from the Phase 3 TIVO-3 Study of Tivozanib in Renal Cell Carcinoma |
|
| 57 | 'When I Started Digging, I Was Horrified': What We Heard This Week |
|
| 58 | Subcutaneous Daratumumab-Based Regimen Effective for Advanced MM |
|
| 59 | MERECA Trial Meets OS Endpoint with Ilixadencel/Sunitinib in mRCC |
|
| 60 | Fred Hutch researchers present virtually at the 2020 American Society of Clinical Oncology meeting |
|
| 61 | Cancer Care From the COVID-19 Frontlines: “Flying by the Seat of Our Pants” |
|
| 62 | Atreca Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program |
|
| 63 | Gracell Announces Two Presentations at the Annual Meeting of American Society of Clinical Oncology (ASCO) |
|
| 64 | Punjab govt’s delayed response suspends free treatment to cancer patients |
|
| 65 | TYME Announces SM-88 Abstract Selected for Presentation at the American Society of Clinical Oncology 2021 Gastrointestinal Cancers Symposium |
|
| 66 | Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium |
|
| 67 | Zanidatamab Clinical Data Selected for Oral Presentation at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium |
|
| 68 | A New Standard of Care in Treatment of Advanced Urothelial Carcinoma from JAVELIN Bladder 100 |
|
| 69 | Purple Biotech Provides Corporate Update and Reports Second Half and Full Year 2020 Financial Results |
|
| 70 | Breaking Research News from Annual Meeting of American Society of Clinical Oncology |
|
| 71 | Hutchison China MediTech Limited Reports 2020 Full Year Results and Provides Business Updates and Evolves Corporate Identity |
|
| 72 | Agios Submits Supplemental New Drug Application to FDA for TIBSOVO® (ivosidenib tablets) for Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma |
|
| 73 | Loxo Oncology at Lilly Announces Publication of Pirtobrutinib (LOXO-305) Phase 1/2 Data in The Lancet |
|
| 74 | Bladder Cancer Therapeutics Market Trends 2020: Latest Devices, Key Players Statistics Data, Regiona |
|
| 75 | CytomX Therapeutics Clinical Programs Highlighted at American Society of Clinical Oncology ASCO20 Virtual Scientific Program |
|
| 76 | Janssen Presents Results from Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA® (apalutamide) and ZYTIGA® (abiraterone acetate) Combination |
|
| 77 | Leading Expert in Women’s Cancers Appointed Director of Gynecologic Oncology at Perlmutter Cancer Center |
|
| 78 | RAPT Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Virtual Scientific Program |
|
| 79 | Tiziana Lifesciences Announces Online Publication of Two Abstracts at the American Society of Clinical Oncology (ASCO) Reporting Clinical Activity and Safety of Milciclib in Patients with Advanced Hepatocellular Carcinoma |
|
| 80 | CytomX Therapeutics Announces Presentations at the 2020 American Society of Clinical Oncology Virtual Scientific Program |
|
| 81 | Zymeworks Reports 2020 Year-End Financial Results |
|
| 82 | BERG Presents Results of Phase 1 Clinical Study in Glioblastoma at 2020 American Society of Clinical Oncology (ASCO) Meeting |
|
| 83 | EnGeneIC Announces Acceptance of Abstract to the Annual Meeting of the American Society of Clinical Oncology 2020 |
|
| 84 | CytomX Therapeutics Announces Details of Presentations at the American Society of Clinical Oncology ASCO20 Virtual Scientific Program |
|
| 85 | Boundless Bio Announces Poster Presentation at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting |
|
| 86 | At 12.3% CAGR, Metastasis Cancer Treatment Market Size Worth $161.67 Billion | Global Industry Research on Growth, Trends, Opportunity, and Analysis in 2027 | |
|
| 87 | Frontline ICI Therapy Gains Traction Across NSCLC Settings |
|
| 88 | SWOG Cancer Research Network shines at ASCO Quality of Care Symposium |
|
| 89 | iCAD Presents Positive New Clinical Data for Xoft Brain IORT at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program |
|
| 90 | Ronald Chen elected as Fellow to American Society of Clinical Oncology |
|
| 91 | FDA Receives New Drug Application for Ivosidenib in IDH1+ Cholangiocarcinoma |
|
| 92 | Spring Bank Announces Poster Presentation at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting |
|
| 93 | Pittsboro drug startup, National Cancer Institute team up to tackle metastatic prostate cancer |
|
| 94 | Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results |
|
| 95 | Neoadjuvant combination immunotherapy improves outcomes for early stage non-small cell lung cancer |
|
| 96 | American Society of Clinical Oncology (ASCO) Abstract Reports Initial ALLO-501 ALPHA Phase 1 Data in Relapsed/Refractory Non-Hodgkin Lymphoma |
|
| 97 | Medidata Announces New Research Published at American Society for Clinical Oncology Annual Meeting |
|
| 98 | T-cell Acute Lymphoblastic Leukemia Market: Increased Clinical Trials to Pump up Market Demand | |
|
| 99 | American Society of Clinical Oncology (ASCO) 2016 Annual Meeting |
|
| 100 | What Is Clinical Utility in a Tumor Biomarker Test? Former ASCO President Knows It When He Sees It |
|